These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29348832)

  • 1. Clinical and histological features of primary testicular diffuse large B-cell lymphoma: a single center experience in China.
    Zhou D; Bao C; Ye X; Zhu L; Zhu J; Li L; Zhu M; Yang X; Zheng Y; Huang X; Xie M; Xie W
    Oncotarget; 2017 Dec; 8(68):112384-112389. PubMed ID: 29348832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience.
    Kim J; Yoon DH; Park I; Kim S; Park JS; Lee SW; Huh J; Park CS; Suh C
    Blood Res; 2014 Sep; 49(3):170-6. PubMed ID: 25325036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium.
    Deng L; Xu-Monette ZY; Loghavi S; Manyam GC; Xia Y; Visco C; Huh J; Zhang L; Zhai Q; Wang Y; Qiu L; Dybkær K; Chiu A; Perry AM; Zhang S; Tzankov A; Rao H; Abramson J; Sohani AR; Xu M; Hsi ED; Zhu J; Ponzoni M; Wang S; Li L; Zhang M; Ferreri AJ; Parsons BM; Li Y; Piris MA; Medeiros LJ; Young KH
    Leukemia; 2016 Feb; 30(2):361-72. PubMed ID: 26308769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
    Vitolo U; Chiappella A; Ferreri AJ; Martelli M; Baldi I; Balzarotti M; Bottelli C; Conconi A; Gomez H; Lopez-Guillermo A; Martinelli G; Merli F; Novero D; Orsucci L; Pavone V; Ricardi U; Storti S; Gospodarowicz MK; Cavalli F; Sarris AH; Zucca E
    J Clin Oncol; 2011 Jul; 29(20):2766-72. PubMed ID: 21646602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma.
    Mannisto S; Vähämurto P; Pollari M; Clausen MR; Jyrkkiö S; Kellokumpu-Lehtinen PL; Kovanen P; Karjalainen-Lindsberg ML; d'Amore F; Leppä S
    Eur J Cancer; 2019 Jul; 115():27-36. PubMed ID: 31082690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of prophylactic irradiation to the contralateral testis for patients with advanced-stage primary testicular lymphoma: an analysis of outcomes at a single institution.
    Tokiya R; Yoden E; Konishi K; Kamitani N; Hiratsuka J; Koresawa R; Hirose T; Sano F; Tokunaga H; Kondo T; Wada H; Sugihara T
    Int J Hematol; 2017 Oct; 106(4):533-540. PubMed ID: 28612278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Testicular Lymphoma: Single Center Experience.
    Shah S; Sreenivasan S; Kancharla P; Khan C; Samhouri Y
    Cancer Diagn Progn; 2023; 3(2):139-144. PubMed ID: 36875297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of LDH Ratio in Serum/Cerebral Spinal Fluid of Patients with Primary Testicular Diffuse Large B-Cell Lymphoma.
    Liu YZ; Luo P; Liu C; Xue K; Jin J; Xia ZG; Liu XJ; Zhang QL; Cao JN; Hong XN; Lv FF
    Onco Targets Ther; 2019; 12():10469-10475. PubMed ID: 31819527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
    Tai WM; Chung J; Tang PL; Koo YX; Hou X; Tay KW; Quek R; Tao M; Lim ST
    Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
    Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
    Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
    Kridel R; Telio D; Villa D; Sehn LH; Gerrie AS; Shenkier T; Klasa R; Slack GW; Tan K; Gascoyne RD; Connors JM; Savage KJ
    Br J Haematol; 2017 Jan; 176(2):210-221. PubMed ID: 27739058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of survival and treatment outcome of patients with primary diffuse large B cell lymphoma in reproductive system].
    Yang P; Zhen JF; Pang M; Hu K; Zhao W; Dong F; Tian L; Ke XY; Jing HM
    Zhonghua Yi Xue Za Zhi; 2018 May; 98(20):1593-1596. PubMed ID: 29886651
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary testicular lymphoma].
    Motyčková M; Vosáhlová V; Belada D; Šimkovič M; Žák P
    Vnitr Lek; 2017; 63(6):415-422. PubMed ID: 28840738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China.
    Chen B; Cao DH; Lai L; Guo JB; Chen ZY; Huang Y; Qiu S; Lin TH; Gou Y; Ma N; Yang L; Liu LR; Wei Q
    BMC Cancer; 2020 Mar; 20(1):220. PubMed ID: 32171265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-center experience in the treatment of primary testicular lymphoma.
    Mihaljevic B; Vukovic V; Smiljanic M; Milic N; Todorovic M; Bila J; Andjelic B; Djurasinovic V; Jelicic J; Antic D
    Oncol Res Treat; 2014; 37(5):239-42. PubMed ID: 24853782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma.
    Ma'koseh M; Tamimi F; Abufara A; Abusalem L; Salama O; Saleh Y; Khader R; Faiyoumi BA; Al-Rwashdeh M; Halahleh K
    Cureus; 2021 Aug; 13(8):e16802. PubMed ID: 34513408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry.
    Wudhikarn K; Bunworasate U; Julamanee J; Lekhakula A; Chuncharunee S; Niparuck P; Ekwattanakit S; Khuhapinant A; Norasetthada L; Nawarawong W; Makruasi N; Kanitsap N; Sirijerachai C; Chansung K; Wong P; Numbenjapon T; Prayongratana K; Suwanban T; Wongkhantee S; Praditsuktavorn P; Intragumtornchai T;
    Ann Hematol; 2017 Jan; 96(1):57-64. PubMed ID: 27752821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
    Guirguis HR; Cheung MC; Mahrous M; Piliotis E; Berinstein N; Imrie KR; Zhang L; Buckstein R
    Br J Haematol; 2012 Oct; 159(1):39-49. PubMed ID: 22849793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era.
    Ferreri AJ; Bruno-Ventre M; Donadoni G; Ponzoni M; Citterio G; Foppoli M; Vignati A; Scarfò L; Sassone M; Govi S; Caligaris-Cappio F
    Br J Haematol; 2015 Mar; 168(5):654-62. PubMed ID: 25312994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.